Redcare Pharmacy NV (LTS:0RJT)
€ 147.25 1.8 (1.24%) Market Cap: 2.98 Bil Enterprise Value: 3.01 Bil PE Ratio: 0 PB Ratio: 5.97 GF Score: 79/100

Q1 2024 Redcare Pharmacy NV Earnings Call Transcript

Apr 25, 2024 / 09:00AM GMT
Release Date Price: €133.85 (-4.22%)
Olaf Heinrich
Redcare Pharmacy NV - CEO

Thank you very much. Good morning, everybody, and a very warm welcome from my side. Let's have a look into today's agenda. We would like to first start with financial performance, then an update on business specialty, and then by the end outlook and guidance.

Let's start with the financial performance first. So Q1 2024 highlight, we continue very strong sales growth, including managed service via 51%, but also organic growth, excluding medical that shows a strong 19% growth. As we look into the non-Rx growth, we are at 20%. And you know, for an online company and also an online pharmacy, it's always important to make the jump at the beginning of the year, and that has always resided with the customer file, which we have been built over the past. That's our capabilities to bring in new customers at the beginning year, and we are really happy that we achieved that sum up to 20%.

As you all know, the e-Rx became mandatory at the beginning of 2024 in Germany. And we saw great adoption rate of above 75%, all of the scripts being lifted. And because of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot